Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany

被引：20
|
作者：
Hoelzer, S
Steiner, D
Bauer, R
Reiners, C
Farahati, J
Hundahl, SA
Dudeck, J
机构：
[1] Univ Giessen, Inst Med Informat, D-35392 Giessen, Germany
[2] Univ Giessen, Clin Nucl Med, D-35392 Giessen, Germany
[3] Univ Wurzburg, Clin & Policlin Nucl Med, D-97070 Wurzburg, Germany
[4] Amer Coll Surg, Commiss Canc, Chicago, IL USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 2000年 / 27卷 / 10期
关键词：
differentiated thyroid cancer; guidelines; radioiodine; treatment;
D O I：
10.1007/s002590000333
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
This prospective, observational study of a cohort of thyroid cancer patients in Germany focusses on the "real-world" practice in the management of thyroid cancer patients. This report includes data from 2376 patients with primary differentiated thyroid carcinoma first diagnosed in the year 1996, The study reveals considerable differences in actual practice concerning surgery and radioiodine treatment. The results indicate that consensus is lacking with respect to the multimodality treatment approach for differentiated thyroid carcinoma. Our analysis represents the most current and comprehensive national assessment of presenting patient characteristics, diagnostic tests, treatment and complications for thyroid cancer.
引用
收藏
页码：1465 / 1472
页数：8
相关论文
共 50 条
  • [1] Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany
    Simon Hoelzer
    Dagmar Steiner
    Richard Bauer
    Christoph Reiners
    Jamshid Farahati
    Scott A. Hundahl
    Joachim Dudeck
    European Journal of Nuclear Medicine, 2000, 27 : 1465 - 1472
  • [2] Risk management of radioiodine treatment in differentiated thyroid cancer
    Villena-Salinas, J.
    Alcocer, M. A. Sempere
    Peinado, M. Gallego
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2024, 43 (04):
  • [3] Radioiodine treatment for differentiated thyroid cancer
    Vini, L
    Harmer, C
    CLINICAL ONCOLOGY, 2000, 12 (06) : 365 - 372
  • [4] THYROID SUPPRESSION AND RADIOIODINE TREATMENT FOR DIFFERENTIATED THYROID-CANCER
    ROSLER, H
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1987, 113 (07) : 778 - 778
  • [5] THE USE OF RADIOIODINE IN THE MANAGEMENT OF THE DIFFERENTIATED THYROID-CANCER
    BESTAGNO, MF
    PAGLIAINI, R
    MAIRA, G
    TERZI, A
    JOURNAL OF RADIOANALYTICAL CHEMISTRY, 1981, 65 (1-2): : 239 - 249
  • [6] The changing role of radioiodine in the management of differentiated thyroid cancer
    Reynolds, JC
    Robbins, J
    SEMINARS IN NUCLEAR MEDICINE, 1997, 27 (02) : 152 - 164
  • [7] Radioiodine treatment of well-differentiated thyroid cancer
    Leonard Wartofsky
    Douglas Van Nostrand
    Endocrine, 2012, 42 : 506 - 513
  • [8] Oxidative stress and radioiodine treatment of differentiated thyroid cancer
    Buczynska, Angelika
    Sidorkiewicz, Iwona
    Rogucki, Mariusz
    Siewko, Katarzyna
    Adamska, Agnieszka
    Kosciuszko, Maria
    Maliszewska, Katarzyna
    Kozlowska, Gabryela
    Szumowski, Piotr
    Mysliwiec, Janusz
    Dzieciol, Janusz
    Kretowski, Adam
    Poplawska-Kita, Anna
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [9] Treatment strategy by radioiodine refractory differentiated thyroid cancer
    Mantsopoulos, Konstantinos
    Mueller, Sarina K.
    Pavel, Marianne
    Kuwert, Torsten
    Meidenbauer, Norbert
    Fietkau, Rainer
    Sievert, Matti
    Iro, Heinrich
    LARYNGO-RHINO-OTOLOGIE, 2022, 101 (04) : 298 - 303
  • [10] Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer
    Maxon, HR
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE, 1999, 43 (04): : 313 - 323
12345